Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Revenue by Segment

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Transcatheter Aortic Valve Replacement	-	4.14B	4.11B	4.05B	3.99B	3.94B	3.88B	3.77B	3.67B
Transcatheter Aortic Valve Replacement Growth	-	5.20%	5.83%	7.46%	8.65%	9.90%	10.28%	6.99%	4.32%
Surgical Structural Heard	968.60M	966.10M	981.30M	1.02B	1.03B	1.02B	999.30M	975.20M
Surgical Structural Heard Growth	-5.52%	-5.02%	-1.80%	4.45%	8.11%	10.51%	11.89%	9.54%
Critical Care	-	-	-	-	-	957.50M	928.10M	902.60M	888.90M	864.80M	855.00M	841.60M	847.00M
Critical Care Growth	-	-	-	-	-	10.72%	8.55%	7.25%	4.95%	1.57%	2.41%	2.45%	7.26%
Transcatheter Mitral and Tricuspid Therapies	445.90M	394.40M	352.10M	303.00M	264.30M	228.90M	197.60M	173.10M
Transcatheter Mitral and Tricuspid Therapies Growth	68.71%	72.30%	78.19%	75.04%	75.73%	75.13%	70.20%	57.51%

Revenue by Geography

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
United States	3.18B	3.10B	3.21B	3.46B	3.52B	3.60B	3.51B	3.41B
United States Growth	-9.79%	-13.78%	-8.63%	1.37%	5.86%	11.39%	12.01%	10.83%
Europe	1.34B	1.30B	1.32B	1.37B	1.37B	1.37B	1.33B	1.28B
Europe Growth	-2.36%	-5.51%	-0.96%	6.85%	11.59%	14.76%	13.59%	7.29%
Rest of World	566.20M	543.30M	572.00M	656.40M	688.10M	722.80M	709.20M	677.30M
Rest of World Growth	-17.72%	-24.83%	-19.35%	-3.09%	5.05%	16.28%	17.92%	14.33%
Japan	318.70M	310.80M	339.80M	391.60M	418.60M	449.10M	452.40M	451.50M
Japan Growth	-23.87%	-30.79%	-24.89%	-13.27%	-6.40%	-0.69%	-4.48%	-9.95%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.